Dr. Andrew Ko serves as a site PI on the Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis (RESET-RA) study and UW was a neurosurgical implant site for the study which will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to biologic or targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs). Read the New York Times story here.